secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-01-27T23:59:59+00:00
Accession:  0001493152-23-002757
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX draws remaining $500K under Secured Note, reaches $13.16M max; issues 340K warrants at $0.735
--------------------------------------------------------------------------------

- Borrowed final $500,000 on Jan 25, 2023, reaching the $13,160,000 maximum principal under the Secured Convertible Note with Juvenescence.
- Outstanding principal due Feb 14, 2024; interest replaced by Origination Fee of 4% per draw plus additional 4% after 12-month draw period.
- Will issue warrants for 340,136 shares of common stock at $0.735 per share to Juvenescence, subject to NYSE American listing approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223002757/0001493152-23-002757-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223002757/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-002757

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer